Pricing Log in Create free account

Entrada Therapeutics, Inc. (TRDA) vs Whitehawk Therapeutics, Inc. (WHWK)

Entrada Therapeutics, Inc. and Whitehawk Therapeutics, Inc. are both Biotechnology companies. Entrada Therapeutics, Inc. and Whitehawk Therapeutics, Inc. are of similar size ($191.5M and $178.4M). Whitehawk Therapeutics, Inc. grew revenue faster over the last twelve months: 16.5% against −93.5%. Whitehawk Therapeutics, Inc. has the higher net margin (0.00% vs −4,058.0%) and the higher return on invested capital (0.00% vs −2,009.0%). Across the 16 metrics below, Whitehawk Therapeutics, Inc. leads on 14 and Entrada Therapeutics, Inc. on 2.

Valuation

Metric TRDA WHWK Biotechnology median
P/E n/m n/m 10.60
P/S 52.10 9.34 9.40
P/B 1.04 1.42 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 3.57 2.54 9.02
Earnings yield (78.53%) (35.78%) (32.88%)
Free cash flow yield (65.80%) (26.94%) (23.13%)

Profitability

Metric TRDA WHWK Biotechnology median
Gross margin 100.00% 88.72% 68.51%
Operating margin (4,303.82%) 0.00% 0.00%
Net margin (4,057.98%) 0.00% 0.00%
Free cash flow margin (3,428.06%) 0.00% 0.00%
Return on equity (59.88%) (44.98%) (51.96%)
Return on assets (47.48%) (42.60%) (46.06%)
Return on invested capital (2,008.96%) 0.00% 0.00%

Growth

Metric TRDA WHWK Biotechnology median
Revenue growth (TTM) (93.54%) 16.51% 6.76%
EPS growth (last fiscal year) (306.55%) 86.02% 29.88%
Revenue growth, 5-year CAGR — (13.29%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TRDA WHWK Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.85 17.38 4.97
Net debt to EBITDA 1.88 1.26 1.01

Dividend

Metric TRDA WHWK Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric TRDA WHWK Biotechnology median
Market cap 191.45m 178.44m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack